PDF herunterladen
CC BY-NC-ND 4.0 · Revista Urología Colombiana / Colombian Urology Journal 2019; 28(02): 106-120
DOI: 10.1055/s-0038-1645846
Review Articles | Artículos de Revisión
Sociedad Colombiana de Urología. Publicado por Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Epidemiología del cáncer de vejiga con énfasis en Colombia - revisión de la literatura

Epidemiology of Bladder Cancer with Emphasis in Colombia - Review of the Literature
Mauricio Medina-Rico
1   Departamento de Epidemiología Clínica y Bioestadística, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia
,
Manuel Lobo
2   Estudiante de 5to año de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia
,
Jorge Romo
2   Estudiante de 5to año de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia
,
Juan Guillermo Prada
2   Estudiante de 5to año de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia
,
Hugo López-Ramos
3   Departamento de Urología, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia
› Institutsangaben
Weitere Informationen

Publikationsverlauf

15. September 2017

09. März 2018

Publikationsdatum:
24. April 2018 (online)

Auch verfügbar auf
   Lizenzen und Reprints

Resumen

Introducción El cáncer de vejiga es el noveno cáncer más frecuente para ambos sexos con una incidencia en ascenso. Habiendo una aparente relación entre el desarrollo de los países y la epidemiología del cáncer; el objetivo de este artículo es observar la epidemiología del cáncer de vejiga en nuestro medio respecto a otros países y describir los posibles factores asociados.

Métodos Se realizó una revisión de la literatura en cuatro bases de datos: Medline, Embase, Cochrane database y Lilacs. Se incluyeron estudios de incidencia, prevalencia, mortalidad, sobrevida y carga de enfermedad, publicados en los últimos 5 años.

Resultados Se encontraron 7806 referencias que fueron discriminadas por título y resumen, incluyendo al final 44 referencias en texto completo. Se observaron tasas de incidencia y mortalidad diferentes, siendo las más altas las encontradas en Europa principalmente en la República Checa seguido de Norte América. En Colombia, la incidencia general es de 6,8/100.000 en hombres y 2,1/100.000 en mujeres entre 2003 y 2007, encontrando cifras bajas en departamentos como la Guajira.

Conclusiones Se ha observado un ascenso en la incidencia y mortalidad del cáncer de vejiga a nivel global. Parece haber una asociación con el tabaquismo y la dieta, así como con el Índice de Desarrollo Humano. Existe una escasa información en Latino América. En Colombia, observando los datos de algunos departamentos y la distribución de especialistas por regiones, se puede suponer un sub-registro haciendo necesario mejorar los sistemas de vigilancia, así como las políticas de salud para el diagnóstico e intervención temprana del cáncer.

Abstract

Introduction Bladder cancer is the ninth most common cancer for both sexes with an increasing incidence. There is an apparent relationship between the development of countries and the epidemiology of cancer; the objective of this article is to observe the epidemiology of bladder cancer in our environment respect to other countries and to describe the possible associated factors.

Methods A review of the literature was performed in four databases: Medline, Embase, Cochrane database and Lilacs. Studies about Incidence, prevalence, mortality, survival and burden of disease, published in the past 5 years, were included.

Results 7806 references were found that were discriminated by title and abstract, 44 references in full text were included at the end. Different incidence and mortality rates were observed, the highest being found in Europe mainly in the Czech Republic followed by North America. In Colombia, the general incidence was 6.8 / 100,000 in men and 2.1 / 100,000 in women between 2003 and 2007, finding low numbers in departments such as Guajira.

Conclusions There has been an increase in the incidence and mortality of bladder cancer worldwide. There seems to be an association with smoking and diet, as well as with the Human Development Index. There is little information in Latin America; in Colombia, observing the data of some departments and the distribution of specialists in the different regions a sub-register can be consider, making necessary to improve surveillance systems, as well as health policies for the diagnosis and early intervention of cancer.

Palabras Clave

cáncer de vejiga - epidemiología - incidencia - prevalencia - mortalidad - sobrevida

Keywords

bladder cancer - epidemiology - incidence - prevalence - mortality - survival rate

Consideraciones Éticas

Protección de sujetos humanos y animales. Los autores declaran que no se realizaron experimentos en seres humanos o animales para este estudio.


Confidencialidad de los datos. No se aplica


Financiación

Ninguna.


 

  • Bibliografía

  • 1 Ferlay J, Soerjomataram I, Dikshit R. , et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136 (05) E359-E386
    CrossrefPubMedGoogle Scholar
  • 2 Ferlay J, Randi G, Bosetti C. , et al. Declining mortality from bladder cancer in Europe. BJU Int 2008; 101 (01) 11-19
    PubMedGoogle Scholar
  • 3 Mahdavifar N, Ghoncheh M, Pakzad R, Momenimovahed Z, Salehiniya H. Epidemiology, Incidence and Mortality of Bladder Cancer and their Relationship with the Development Index in the World. Asian Pac J Cancer Prev 2016; 17 (01) 381-386
    CrossrefPubMedGoogle Scholar
  • 4 Bernal-Pérez M, Souza DL, Romero-Fernández FJ, Gómez-Bernal G, Gómez-Bernal FJ. Estimation of bladder cancer projections in Spain. Actas Urol Esp 2013; 37 (05) 286-291
    CrossrefPubMedGoogle Scholar
  • 5 Ljungberg B, Campbell SC, Choi HY. , et al. The epidemiology of renal cell carcinoma. Eur Urol 2011; 60 (04) 615-621
    CrossrefPubMedGoogle Scholar
  • 6 Burger M, Catto JWF, Dalbagni G. , et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013; 63 (02) 234-241
    CrossrefPubMedGoogle Scholar
  • 7 Citarella D, Quiroga Matamoros W, Fernandez F, Patiño I, Estrada A. Guía de manejo en cáncer vesical. Urol Colomb 2016; 25 (02) 154-168
    CrossrefPubMedGoogle Scholar
  • 8 Pardo C, Cendales R. Incidencia, mortalidad y prevalencia de Cáncer en Colombia 2007–2011. Inst Nac Cancerol 2015; 1: 36-37
    PubMedGoogle Scholar
  • 9 Bravo LE, Collazos T, Collazos P, García LS, Correa P. Trends of cancer incidence and mortality in Cali, Colombia. 50 years experience. Colomb Med (Cali) 2012; 43 (04) 246-255
    PubMedGoogle Scholar
  • 10 Piñeros M, Ferlay J, Murillo R. Cancer incidence estimates at the national and district levels in Colombia. Salud Publica Mex 2006; 48 (06) 455-465
    CrossrefPubMedGoogle Scholar
  • 11 Crocetti E, De Angelis R, Buzzoni C. , et al; AIRTUM Working group. Cancer prevalence in United States, Nordic Countries, Italy, Australia, and France: an analysis of geographic variability. Br J Cancer 2013; 109 (01) 219-228
    CrossrefPubMedGoogle Scholar
  • 12 Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J. , et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49 (06) 1374-1403
    CrossrefPubMedGoogle Scholar
  • 13 Vrdoljak E, Wojtukiewicz MZ, Pienkowski T. , et al; South Eastern European Research Oncology Group. Cancer epidemiology in Central, South and Eastern European countries. Croat Med J 2011; 52 (04) 478-487
    CrossrefPubMedGoogle Scholar
  • 14 Bosetti C, Bertuccio P, Chatenoud L, Negri E, La Vecchia C, Levi F. Trends in mortality from urologic cancers in Europe, 1970-2008. Eur Urol 2011; 60 (01) 1-15
    CrossrefPubMedGoogle Scholar
  • 15 Marcos-Gragera R, Mallone S, Kiemeney LA. , et al; EUROCARE-5 Working Group. Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5. Eur J Cancer 2015; 51 (15) 2217-2230
    CrossrefPubMedGoogle Scholar
  • 16 Gatta G, Mallone S, van der Zwan JM, Trama A, Siesling S, Capocaccia R. ; EUROCARE Working Group. Cancer prevalence estimates in Europe at the beginning of 2000. Ann Oncol 2013; 24 (06) 1660-1666
    CrossrefPubMedGoogle Scholar
  • 17 Dusek L, Muzik J, Maluskova D. , et al. Cancer incidence and mortality in the Czech Republic. Klin Onkol 2014; 27 (06) 406-423
    CrossrefPubMedGoogle Scholar
  • 18 Mihajlović J, Pechlivanoglou P, Miladinov-Mikov M, Zivković S, Postma MJ. Cancer incidence and mortality in Serbia 1999-2009. BMC Cancer 2013; 13 (01) 18
    CrossrefPubMedGoogle Scholar
  • 19 Mistry M, Parkin DM, Ahmad AS, Sasieni P. Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer 2011; 105 (11) 1795-1803
    CrossrefPubMedGoogle Scholar
  • 20 Cooter M, Soliman AS, Pavlou P. , et al. Incidence and time trends of cancer in Cyprus over 11 years (1998-2008). Tumori 2015; 101 (01) 8-15
    CrossrefPubMedGoogle Scholar
  • 21 Andreassen BK, Aagnes B, Gislefoss R, Andreassen M, Wahlqvist R. Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014. BMC Cancer 2016; 16 (01) 799
    CrossrefPubMedGoogle Scholar
  • 22 Arfè A, Malvezzi M, Bertuccio P, Decarli A, La Vecchia C, Negri E. Cancer mortality trend analysis in Italy, 1970-2007. Eur J Cancer Prev 2011; 20 (05) 364-374
    CrossrefPubMedGoogle Scholar
  • 23 Colonna M, Mitton N, Bossard N, Belot A, Grosclaude P. ; French Network of Cancer Registries (FRANCIM). Total and partial cancer prevalence in the adult French population in 2008. BMC Cancer 2015; 15 (01) 153
    CrossrefPubMedGoogle Scholar
  • 24 Westlake S, Cooper N, Rachet B, Coleman MP. Survival from cancers of the kidney and ureter in England and Wales up to 2001. Br J Cancer 2008; 99 (Suppl. 01) S93-S95
    CrossrefPubMedGoogle Scholar
  • 25 Pelant T, Larsen EH, Lund L. , et al. Survival of patients with kidney cancer in central and northern Denmark, 1998-2009. Clin Epidemiol 2011; 3 (Suppl. 01) 53-58
    PubMedGoogle Scholar
  • 26 Engholm G, Hakulinen T, Gislum M. , et al. Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010; 49 (05) 655-664
    CrossrefPubMedGoogle Scholar
  • 27 Bouchbika Z, Haddad H, Benchakroun N. , et al. Cancer incidence in Morocco: report from Casablanca registry 2005-2007. Pan Afr Med J 2013; 16: 31
    PubMedGoogle Scholar
  • 28 Tazi MA, Er-Raki A, Benjaafar N. Cancer incidence in Rabat, Morocco: 2006-2008. Ecancermedicalscience 2013; 7: 338
    PubMedGoogle Scholar
  • 29 Masoompour SM, Lankarani KB, Honarvar B, Tabatabaee SH, Moghadami M, Khosravizadegan Z. Changing Epidemiology of Common Cancers in Southern Iran, 2007-2010: A Cross Sectional Study. PLoS One 2016; 11 (05) e0155669
    CrossrefPubMedGoogle Scholar
  • 30 Basiri A, Shakhssalim N, Jalaly NY, Miri HH, Partovipour E, Panahi MH. Difference in the incidences of the most prevalent urologic cancers from 2003 to 2009 in Iran. Asian Pac J Cancer Prev 2014; 15 (03) 1459-1463
    CrossrefPubMedGoogle Scholar
  • 31 El Mistiri M, Salati M, Marcheselli L. , et al. Cancer incidence, mortality, and survival in Eastern Libya: updated report from the Benghazi Cancer Registry. Ann Epidemiol 2015; 25 (08) 564-568
    CrossrefPubMedGoogle Scholar
  • 32 Pakzad R, Mohammadian-Hafshejani A, Mohammadian M. , et al. Incidence and Mortality of Bladder Cancer and their Relationship with Development in Asia. Asian Pac J Cancer Prev 2015; 16 (16) 7365-7374
    CrossrefPubMedGoogle Scholar
  • 33 Chen W, Zheng R, Zhang S. , et al. The incidences and mortalities of major cancers in China, 2009. Chin J Cancer 2013; 32 (03) 106-112
    CrossrefPubMedGoogle Scholar
  • 34 Yang Y, Xie L, Zheng J-L, Tan Y-T, Zhang W, Xiang Y-B. Incidence trends of urinary bladder and kidney cancers in urban Shanghai, 1973-2005. PLoS One 2013; 8 (12) e82430
    CrossrefPubMedGoogle Scholar
  • 35 Guo P, Huang ZL, Yu P, Li K. Trends in cancer mortality in China: an update. Ann Oncol 2012; 23 (10) 2755-2762
    CrossrefPubMedGoogle Scholar
  • 36 Zaitsu M, Toyokawa S, Tonooka A. , et al. Sex differences in bladder cancer pathology and survival: analysis of a population-based cancer registry. Cancer Med 2015; 4 (03) 363-370
    CrossrefPubMedGoogle Scholar
  • 37 Poudel KK, Huang Z, Neupane PR. Age specific incidence of five major cancers in Nepal, 2012. Nepal J Epidemiol 2016; 6 (02) 565-573
    PubMedGoogle Scholar
  • 38 Jung K-W, Park S, Kong H-J. , et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat 2012; 44 (01) 11-24
    CrossrefPubMedGoogle Scholar
  • 39 Jung K-W, Won Y-J, Kong H-J. , et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 2015; 47 (02) 127-141
    CrossrefPubMedGoogle Scholar
  • 40 Ranasinghe WKB, De Silva D, De Silva MVC. , et al. Incidence of bladder cancer in sri lanka: analysis of the cancer registry data and review of the incidence of bladder cancer in the South asian population. Korean J Urol 2012; 53 (05) 304-309
    CrossrefPubMedGoogle Scholar
  • 41 Australian Institute of Health and Welfare. Cancer in Australia: Actual incidence data from 1991 to 2009 and mortality data from 1991 to 2010 with projections to 2012. Asia Pac J Clin Oncol 2013; 9 (03) 199-213
    CrossrefPubMedGoogle Scholar
  • 42 Yu XQ, Baade PD, O'Connell DL. Conditional survival of cancer patients: an Australian perspective. BMC Cancer 2012; 12 (01) 460
    CrossrefPubMedGoogle Scholar
  • 43 Anikeeva O, Bi P, Hiller JE, Ryan P, Roder D, Han G-S. Trends in cancer mortality rates among migrants in Australia: 1981-2007. Cancer Epidemiol 2012; 36 (02) e74-e82
    CrossrefPubMedGoogle Scholar
  • 44 Abdollah F, Gandaglia G, Thuret R. , et al. Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis. Cancer Epidemiol 2013; 37 (03) 219-225
    CrossrefPubMedGoogle Scholar
  • 45 Zhang Y, Zhu C, Curado MP, Zheng T, Boyle P. Changing patterns of bladder cancer in the USA: evidence of heterogeneous disease. BJU Int 2012; 109 (01) 52-56
    PubMedGoogle Scholar
  • 46 Nielsen ME, Smith AB, Meyer A-M. , et al. Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006. Cancer 2014; 120 (01) 86-95
    CrossrefPubMedGoogle Scholar
  • 47 Kamel MH, Moore PC, Bissada NK, Heshmat SM. Potential years of life lost due to urogenital cancer in the United States: trends from 1972 to 2006 based on data from the SEER database. J Urol 2012; 187 (03) 868-871
    CrossrefPubMedGoogle Scholar
  • 48 Scosyrev E, Golijanin D, Wu G, Messing E. The burden of bladder cancer in men and women: analysis of the years of life lost. BJU Int 2012; 109 (01) 57-62
    PubMedGoogle Scholar
  • 49 Chatenoud L, Bertuccio P, Bosetti C. , et al. Trends in mortality from major cancers in the Americas: 1980-2010. Ann Oncol 2014; 25 (09) 1843-1853
    CrossrefPubMedGoogle Scholar
  • 50 Colli J, Lee BR, Thomas R. Population densities in relation to bladder cancer mortality rates in America from 1950 to 1994. Int Urol Nephrol 2012; 44 (02) 443-449
    CrossrefPubMedGoogle Scholar
  • 51 López Guarnizo G, Arias Ortiz N, Arboleda Ruiz W. Cancer incidence and mortality in Manizales 2003-2007. Colomb Med (Cali) 2012; 43 (04) 281-289
    PubMedGoogle Scholar
  • 52 Uribe C, Osma S, Herrera V. Cancer incidence and mortality in the Bucaramanga metropolitan area, 2003-2007. Colomb Med (Cali) 2012; 43 (04) 290-297
    PubMedGoogle Scholar
  • 53 Yépez MC, Bravo LE, HidalgoTroya A, Jurado DM, Bravo LM. Cancer incidence and mortality in the municipality of Pasto, 1998 - 2007. Colomb Med (Cali) 2012; 43 (04) 256-266
    PubMedGoogle Scholar
  • 54 World Bank Country and Lending Groups – World Bank Data Help Desk. The world bank. Cited on May 15, 2017. Avaliable at: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
    PubMed
  • 55 Juliao SeniorA.. Urología Colombiana, Ejercicio Profesional en Ciudades Intermedias. Urol Colomb 2002; 11 (03) 212-220
    PubMedGoogle Scholar
  • 56 García-Perdomo HA. Conceptos fundamentales de las revisiones sistemáticas/metaanálisis. Urol Colomb. 2015; 24 (01) 28-34
    CrossrefPubMedGoogle Scholar